Search results
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From...
Benzinga via Yahoo Finance· 1 year agoMore than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking...
Cost of lead poisoning drug jumps from $3,500 to $32,000, making it hard for hospitals to stock
CNN via Yahoo News· 6 months agoIn August, the US Food and Drug Administration greenlit a new maker of an old drug used for the most...
Bill Ackman's latest short is a 'smart lottery ticket' bet against the Hong Kong dollar – here are 7...
Business Insider via Yahoo Finance· 1 year agoBill Ackman is shorting the Hong Kong dollar for his latest trade.Richard Drew/AP Billionaire...
Brent Saunders to return as Bausch + Lomb CEO
Reuters via Yahoo Finance· 1 year ago(Reuters) -Bausch + Lomb Corp on Wednesday named Brent Saunders, the former chief executive officer of Allergan, as its CEO and chairman of board,...
Nio falls after short seller says the Chinese EV maker plays 'accounting games' to boost financial...
Business Insider via Yahoo Finance· 2 years agoThe Nio lineup.Nio Nio shares fell as much as 5% Wednesday after a short seller said the EV firm was...
A 'Toxic Byproduct of an Imperfect Higher Education System' — Famous Short Seller Known as 'The...
Benzinga via Yahoo Finance· 4 months agoFahmi Quadir, featured in the Netflix series "Dirty Money" for her success in predicting and betting...
UPDATE 2-Bausch Health suspends plans for Solta IPO
Reuters via Yahoo Finance· 2 years agoBausch Health Companies Inc said on Thursday it was suspending plans for the initial public offering of its unit Solta Medical due to challenging market conditions. It has been a gloomy year ...
Bill Ackman's misguided Harvard crusade
INSIDER via Yahoo News· 7 months agoDavid Orrell/CNBC/NBCU Photo Bank/NBCUniversal via Getty Images; iStock; Insider Like many on Wall Street, the billionaire investor Bill Ackman is full...
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
InvestorPlace via Yahoo Finance· 2 years agoWall Street is still digesting the legal drama impacting embattled pharmaceutical firm Bausch Health (NYSE:BHC). The company has promised to pursue all available options regarding an unfavorable ...
Bausch (BHC) Stock Jumps 19.3%: Will It Continue to Soar?
Zacks via Yahoo Finance· 1 year agoBausch (BHC) was a big mover last session on higher-than-average trading volume. The latest trend in...
